Browse the evidence

An alternative approach to GLP-1 agonist treatment includes long-term lifestyle programming.

Incorporating lifestyle changes alongside GLP-1 treatment may enhance effectiveness.

The approach of 'Food Is Medicine' is suggested to address obesity burdens.

Utilizing appropriate food choices can be a key strategy in obesity management.

Ultrasonography is recommended as the initial screening tool for hepatic steatosis in Latin America.

Practitioners should use ultrasonography for initial screening of MASLD patients.

Complete alcohol abstinence is recommended for patients with significant fibrosis.

Practitioners should advise patients with significant fibrosis to abstain from alcohol.

Bariatric surgery has been the primary approach to treating obese individuals.

Practitioners should consider bariatric surgery as a primary treatment option for obesity.

Long-term results with semaglutide and tirzepatide are approaching the success seen with bariatric surgery.

Practitioners should be aware of the effectiveness of semaglutide and tirzepatide in weight management.

Mendelian randomisation awaits confirmation with RCT and real-world data.

Further research is needed to confirm the findings regarding GLP-1RA and suicide attempts.

Future clinical trials with other incretin mimetics may further emphasize the importance of an obesity phenotype-based approach in treating HFpEF.

Clinicians should stay informed about upcoming trials that may validate obesity phenotype-based treatments.

Final proof of efficacy for incretin therapies on primary clinical liver outcomes may come from large database analyses.

Future studies should focus on analyzing large datasets to confirm the efficacy of incretin therapies for NAFLD.

Ingesting bicarbonate as a hydrogel product may provide an advantage in the marathon.

Explore the potential benefits of bicarbonate supplementation for marathon training.

Collagen supplements may be useful to reduce tendon and ligament injuries in volleyball.

Consider recommending collagen supplementation for volleyball athletes to potentially reduce injury risk.

Cautious use of tirzepatide is vital due to potential adverse effects and contraindications.

Healthcare providers should monitor patients closely for adverse effects when prescribing tirzepatide.

Further interventional studies involving humans are needed to better understand the role of soy isoflavones in PCOS.

More research is necessary to fully understand how soy isoflavones can be effectively used in treating PCOS.

Strategies in supporting health and performance over a player's career are encouraged.

Organizations should hire qualified nutrition professionals to support players' long-term health.

Semaglutide's success in India will depend on affordability, rational prescribing, and integration into preventive care frameworks.

Efforts should focus on making semaglutide accessible and integrating it into broader health strategies.

Further investigations are warranted regarding the effects of GLP-1-based therapies on skeletal muscle.

Practitioners should advocate for more research to better understand the implications of GLP-1 therapies on muscle health.

This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) discusses 30 common obesity myths, misunderstandings, and/or oversimplifications.

Clinicians should be aware of these myths to improve patient care.

Knowledge of the underlying science may assist the obesity medicine clinician improve the care of patients with obesity.

Clinicians should leverage scientific knowledge to enhance patient outcomes.

The scientific support for this CPS is based upon published citations, clinical perspectives of OMA authors, and peer review.

The CPS is grounded in credible scientific and clinical perspectives.

Clinical inertia results in type 2 diabetes not being effectively managed.

Family physicians should be aware of the factors contributing to clinical inertia in T2D management.

Guidelines for antidiabetic drugs should provide case studies and clinical examples.

Improving guidelines with practical examples may enhance their application in clinical settings.

Clear recommendations for personalized T2D management may encourage drug prescription.

Family physicians should utilize clear recommendations to improve drug prescription practices.

Supplementation with flaxseed oil (omega-3 fatty acids) and leucine shows some promise for improving recovery outcomes after ACL reconstruction, but high-quality evidence is lacking.

Flaxseed oil and leucine show some promise for ACL recovery, but current evidence is too weak to recommend them as standard care. Focus on proven strategies like high protein intake and physical therapy first.

Vitamin C and E supplementation (200 IU E and 1000 mg C daily) does not significantly improve functional outcomes, graft rupture rates, or inflammatory markers after ACL reconstruction.

Taking high doses of Vitamin C and E (1000 mg and 200 IU twice daily) does not appear to significantly improve functional outcomes or reduce inflammation after ACL surgery. It is not recommended as a standard part of recovery.